Cvs Share Discussion Threads

[arja] 24/4/2023 14:26

I do not study fundamentals of stocks much but notice this stock has a high debt/equity ratio. But may be good for trading with big intra day movements :)

[arja] 24/4/2023 14:20

can amyone kindly confirm that NO stamp duty is payable when buying this stock ? It has a nice uptrending short term chart .

[lomax99] 14/4/2023 11:32

If Mars wanted to scale up their European investments, interest here would not entirely be a surprise.

[spyder] 14/4/2023 09:02

Yes, the rise this morning is definitely down to the Dechra offer from EQT. It is a clear vote of confidence in the sector.
That said, EQT’s involvement with IVC (the biggest UK vet consolidator) could cause some issues for them?

[babbler] 14/4/2023 08:47

DPH Sympathy

[wad collector] 14/4/2023 08:31

Those broker views have not changed , so not the reason for the uptick.

[lomax99] 14/4/2023 08:28

DPH may be having an indirect impact, whilst focusing on veterinary drugs it shows PE interest in the general sector.

[ariane] 14/4/2023 08:24

Consensus

Mean consensus BUY

Number of Analysts 9

Last Close Price 1 875,00 GBX

Average target price 2 375,63 GBX
Spread / Average Target 26,7%

Might well break through current Resistance and go walkies

[wad collector] 14/4/2023 08:19

Interesting upwards spike this week, no news I can find, no TU due until July.
Maybe just noise.

[wad collector] 03/3/2023 18:31

The other thing about the IC recommendation is that they last recommended Buy in September at 1623p. So they were right then!

[ariane] 02/3/2023 18:53

Consensus

Mean consensus BUY

Number of Analysts 8

Last Close Price 1 869,00 GBX

Average target price 2 377,86 GBX
Spread / Average Target 27,2%

[lomax99] 02/3/2023 18:40

IC:There are few sectors of the UK economy that could claim to be thriving at the moment – but veterinary medicine appears to be one of them. Vet services group CVS (CVSG) reported 7.3 per cent year-on-year revenue growth in its prac- tices in the six months to the end of December.Veterinary surgeries, which account for 86 per cent of group revenue, had to contend with an admittedly slimmer margin at 21 per cent (down from 21.4 per cent in 2021). The company attributed this to increased invest- ment in staff, as well as inflationary pressures.However, volumes look likely to remain stable thanks to the increase in pet ownership seen during the Covid-19 lockdown period. "We expect to see the full benefit of this increased population over the next five to 10 years as these animals reach maturity and may require more frequent and complex veterinary interventions," the company said in its results.CVS is clearly confident in its ability to grow against a gloomy economic backdrop. In the first half of its 2023 financial year, the company completed five acquisitions of eight practice sites for a total consideration of £24.4mn. A focus on growth initiatives also led to an almost-doubling of investment capi- tal expenditure to £19.9mn, versus £10.6mn in the previous year.The group's two other divisions, labs and crematoria, grew their revenue by 7.2 per cent and 10 per cent, respectively, although margins fell for crematoria as fuel costs went up.The board remains confident in the compa- ny's ability to meet expectations for the full financial year. Given the long-term prospects linked to pet demographics, we don't consider a forward rating of 21 times forecast earnings overly optimistic. Buy.

[lomax99] 30/1/2023 06:32

Acquisitive CVS on a roll, says BerenbergVeterinary group CVS (CVSG) has increased its pace of acquisition and combined with its half-year trading update, Berenberg says shareholders should benefit from material returns.Analyst Calum Battersby reiterated his 'buy' recommendation and target price of £23.70 on the stock, which ended last week broadly unchanged at £19.28.A first half 2023 update from the group was in line with Battersby's estimates and at the upper end of management's guided growth range, with like-for-like sales up 7.5% over the period and earnings rising 19%.'More interesting was a further acquisition update, stating that CVS completed the acquisition of nine veterinary practices in the UK in the first half, for a total initial consideration of £26.5m,' he said.'Given that the group has only spent an average of £16m a year over the last three years, this shows that the pace of M&A is increasing, in line with the group's stated ambition to spend upwards of £50m a year on acquisitions over the next five years.'Battersby said the acquisitions combined with the trading update 'supports our investment case, that a combination of organic growth, significant capital investments on practice refurbishments and relocations, and M&A, will all combine to drive a double-digit earnings compound annual growth rate over the next five years, supporting material shareholder returns'.

[ariane] 27/1/2023 10:29

CVS Group optimistic of growth as it anticipates successful first half
01/26/2023 | 12:04pm GMT


(Alliance News) - CVS Group PLC on Thursday said it is trading in line with full-year expectations, and is well-placed to deliver on growth opportunities.

CVS Group is a Norfolk, England-based provider of integrated veterinary services.

For the six months ended December 31, the company expects revenue of GBP296.3 million, up 8.2% from GBP273.7 million on the previous year.

Like-for-like sales are expected to rise 7.5%, within CVS Group's organic revenue growth plan of between 4% and 8%.

Adjusted earnings before interest, tax, depreciation and amortisation should fall within a margin of around 19%, in line with the year prior, it added.

The company said it has continued to increase its investment in practice refurbishment, relocations, clinical equipment and technology, with GBP19.9 million invested in the first half of 2023, compared to GBP10.6 million the previous year.

In December, it opened a new Greenfield site in Southport, and is on track to open a further two in the second half.

CVS Group also completed two acquisitions, bringing its total to six, comprising nine practice sites in the financial year to date, for an initial consideration of GBP26.5 million.

As a result, net borrowing increased to GBP57.6 million, from GBP36.0 million at June 30.

Looking ahead, CVS Group said that while it remained "mindful" of the challenging economic backdrop, it was pleased with its first half performance and "considers that current trading remains in line with market expectations for the full year".

"The group remains well-placed to deliver on further growth opportunities over the longer term," it added.

CVS Group shares were trading 0.9% higher at 1,935.71 pence each in London on Thursday morning.

By Holly Beveridge; Alliance News reporter

Comments and questions to [e-mail]

[1jat] 27/1/2023 08:43

Should we read the like for like sales increase as flat after inflation?

[the grumpy old men] 26/1/2023 08:10

Outlook

Whilst the Group remains mindful of the challenging economic backdrop, demand for veterinary care remains resilient. We continue to focus on our purpose to provide the best possible care to animals through our integrated platform and to invest in our practices and clinical equipment to drive organic growth, whilst continuing to explore acquisition opportunities in both the UK and internationally as outlined at our recent Capital Markets Day .

The Board is pleased with H1 2023 performance and considers that current trading remains in line with market expectations for the full year. The Group remains well placed to deliver on further growth opportunities over the longer term.

[lomax99] 26/1/2023 07:54

Decent update from CVSG. Keen to see them get back on the acquisition trail/build up greenfield sites, assuming delivery at a reasonable cost.

[1jat] 26/12/2022 15:47

Re customers will continue to pay…..early years car is usually low value with more systemic and chronic conditions emerging after 5 years… the business only needs some customers to keep paying up.,..so the material increase in pets during lockdown will continue to flow through into more work for many years…not peaking until 2027 or later.

[ariane] 24/12/2022 12:24

Thursday 26th January 2023 – Trading update

Friday 24th February 2023 – Interim results

Friday 30th June 2023 – Financial year end

Thursday 27th July 2023 – Trading update

Thursday 21st September 2023 – Preliminary results

Wednesday 29th November 2023 – Annual General Meeting and Trading update

Thursday 16th November 2023 – Ex-dividend date for dividend

Friday 17th November 2023 – Record date for dividend

Friday 1st December 2023 – Dividend payment date

[wad collector] 24/12/2022 10:18

IC says BUY , thinks the customers will keep paying the increased bills.

[maywillow] 23/11/2022 08:19

Wednesday 23 November 2022 – Annual General Meeting

Friday 2 December 2022 – Dividend payment date

[waldron] 23/11/2022 08:10

Dividend

As previously announced, and subject to shareholder approval at the AGM, CVS intends to pay a dividend of 7.0 pence per ordinary share on 2 December 2022 to holders on the register as at 18 November 2022. The ex-dividend date for this timetable is 17 November 2022.

Outlook

We continue to focus on our purpose to provide the best possible care to animals through our integrated platform and to invest in our practices and clinical equipment to drive organic growth, whilst continuing to explore acquisition opportunities in both the UK and internationally. Whilst mindful of the wider macro-economic uncertainty, the Group continues to trade in line with full year market expectations and the Group remains well placed to achieve further growth over the longer term and deliver on our ambitions as set out at the CMD.

The Board recognises the opportunity to further increase its diversity, and commenced a formal search process to appoint an additional Non-Executive Director in the previous financial year. The Board is determined to select the most appropriate candidate, and is confident that this search process will be concluded with a suitable appointment in the current financial year.

The Board would like to thank all members of the CVS team for their continued dedication and support.

[waldron] 07/11/2022 19:30

Financial calendar


Thursday 17 November 2022 – Ex-dividend date for dividend

Friday 18 November 2022 – Record date for dividend

Wednesday 23 November 2022 – Annual General Meeting

Friday 2 December 2022 – Dividend payment date

[disc0dave45] 07/11/2022 19:29

Nice bowl on the chart but I'm in two minds whether to chase this or wait......very volatile markets at the moment.